Bright Peak Therapeutics Is A Clinical Stage Biotechnology Company Based In Baselswitzerlandand San Diegocaliforniathe Company Specializes In Developing Next Generation Multifunctional Precision Immunotherapiesfounded By Vijaya Pattabiraman And Jeffrey Bodebright Peak Utilizes A Proprietary Chemical Protein Synthesis Platform To Create And Optimize Natural Proteinsparticularly Cytokinesfor Treating Cancer And Autoimmune Diseases The Company S Lead Programbpt567Is A Bifunctional Pd 1Xil 18 Immunoconjugate Currently In A Phase 1 2A Clinical Trialbright Peak Is Also Advancing Several Undisclosed Multi Functional Pd 1 Programs Aimed At Addressing High Unmet Needs In Cancer Treatmentadditionallythe Company Has A Pipeline Of Cytokine Therapeuticswith Candidates Showing Improved Properties Compared To Existing Il 2 Therapiesbright Peak Has Partnered With Livzon Pharmaceutical Group To Develop Novel Pd 1 Targeted Immunocytokines Using Their Anti Pd 1 Monoclonal Antibodylzm009
